Assessment of Compliance With Antihypertensive Telmisartan Therapy

The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age over 18
Untreated or ineffectively treated arterial hypertension

Exclusion criteria

Cholestatic disorders and severe hepatic failure
Allergy to Telmisartan
Pregnancy and lactation period
Unwillingness to participate in the study
Inability to use the drug reminder device
Unwillingness to use the drug reminder device

Treatment and study plan

Telmisartan (Kinzal/Pritor, BAY68-9291)

Drug

Primary care clinic hypertensive patients for whom physician decided to start the treatment with telmisartan

Primary outcomes

Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand device

Time frame: At all four planned control visits. (Approx. interval between visits 3 months)

Secondary outcomes

Compliance with the treatment calculated on the basis of by HelpingHand and patients questionnaires

Time frame: At all four planned control visits. (Approx. interval between visits 3 months)

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Collaborators

Bang & Olufsen Medicom

Registry information

Official study title

A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy

Acronym: COAST

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: May 8, 2007
Registry last updated: Nov 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed